NCT06971744View on ClinicalTrials.gov

Autophagy Maintenance (AUTOMAIN)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions

Ovarian Cancer

Interventions

DRUG

Hydroxychloroquine

3 x 200 milligram tablets twice daily

DRUG

Nelfinavir

2x 625 milligram tablets twice daily

DRUG

Bevacizumab

IV 15 milligram/kilogram every 3 weeks

All Listed Sponsors

lead

Medical University of South Carolina

OTHER